Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  ferumoxytol non-stoichiometric magnetite
Find trials that include:  Any drugs shown
Results 1-9 of 9 for your search:
Start Over
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors before or after Treatment in Patients with Primary or Metastatic Brain Tumors
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 to 75
Trial IDs: IRB00002864, NCI-2015-00225, SOL-06077-L, NCT00659126
Ferumoxytol Enhanced MRI in Detecting Lymph Node Metastases in Patients with Prostate, Bladder, or Kidney Cancer
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: 14-C-0107, NCI-2014-02482, NCT02141490
Pilot Study to Determine Biodistribution of MM-398 and Feasibility of Ferumoxytol as a Tumor Imaging Agent
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: MM-398-01-01-02, NCI-2016-00161, NCT01770353
Liposomal Irinotecan and Veliparib in Treating Patients with Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9914, NCI-2015-02125, TBD, NCT02631733
DSC-MRI with Ferumoxytol and DCE-MRI with Gadolinium in Imaging Vascular Properties in Younger Patients with Brain Tumors
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and under
Trial IDs: IRB00005405, NCI-2015-00227, 1562, 2864, 813, SOL-09064-LX, NCT00978562
Ferumoxytol-Labeled Magnetic Resonance Imaging in Differentiating Bone Sarcomas and Osteomyelitis
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 10 to 21
Trial IDs: PEDSBONE006, NCI-2011-01367, 20253, NCT01336803
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients with Glioblastoma
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: IRB00009846, NCI-2015-00080, eIRB#9846, SOL-13090-L, NCT02359097
Ferumoxytol-Enhanced MRI in Measuring Inflammatory Responses in the Central Nervous System in Patients with Newly Diagnosed or Recurrent High Grade Glioma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Age: 2 and over
Trial IDs: BRNCNS0007, NCI-2015-00435, NCT02452216
Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients with Stage IIB-IIIC Esophageal Cancer
Status: Not yet active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: IRB00012071, NCI-2016-01093, NCT02857218
Start Over